Literature DB >> 11488652

Treatment of refractory partial status epilepticus with multiple subpial transection: case report.

C H D'Giano1, M Del C García , H Pomata, A L Rabinowicz.   

Abstract

Status epilepticus (SE) represents a medical emergency that annually affects 60,000--150,000 individuals in the United States. Selective neuronal loss in vulnerable areas has been pathologically demonstrated following convulsive SE primarily affecting the limbic system, thalamus and cerebellum. Morbidity in those cases that follow refractory SE (RSE) is poorly documented. There have been anecdotal reports of surgical treatment for this condition, especially secondary to brain lesions. We report a 6-year-old patient who was in RSE for 60 days, without a brain lesion documented by MRI. The patient underwent multiple subpial transection (MST) of the sensorimotor cortex, which by ictal EEG and ictal SPECT proved to be the epileptogenic zone. We conclude that MST should be considered as an alternative treatment for refractory partial SE. Copyright 2001 BEA Trading Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11488652     DOI: 10.1053/seiz.2001.0521

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  10 in total

1.  Multiple Subpial Transections for Medically Refractory Epilepsy: A Disaggregated Review of Patient-Level Data.

Authors:  John D Rolston; Hansen Deng; Doris D Wang; Dario J Englot; Edward F Chang
Journal:  Neurosurgery       Date:  2018-05-01       Impact factor: 4.654

2.  Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting.

Authors:  Stephan J. Rüegg; Marc A. Dichter
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 3.  Anterior Temporal Lobectomy for Refractory Status Epilepticus in Herpes Simplex Encephalitis.

Authors:  Sarah K B Bick; Saef Izzy; Daniel B Rubin; Sahar F Zafar; Eric S Rosenthal; Emad N Eskandar
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

Review 4.  [Refractory status epilepticus: diagnosis, therapy, course, and prognosis].

Authors:  F Bösebeck; G Möddel; K Anneken; M Fischera; S Evers; E B Ringelstein; C Kellinghaus
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

5.  Acute Resective Surgery for the Treatment of Refractory Status Epilepticus.

Authors:  Maysaa Merhi Basha; Kushak Suchdev; Monica Dhakar; William J Kupsky; Sandeep Mittal; Aashit K Shah
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

Review 6.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

7.  The role of neurosurgery in status epilepticus.

Authors:  Yu-Tze Ng; Ruth E Bristol; Dewi V Schrader; Kris A Smith
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 8.  Management of Status Epilepticus in Children.

Authors:  Douglas M Smith; Emily L McGinnis; Diana J Walleigh; Nicholas S Abend
Journal:  J Clin Med       Date:  2016-04-13       Impact factor: 4.241

Review 9.  Status Epilepticus and Beyond: A Clinical Review of Status Epilepticus and an Update on Current Management Strategies in Super-refractory Status Epilepticus.

Authors:  Roy Poblete; Gene Sung
Journal:  Korean J Crit Care Med       Date:  2017-05-31

Review 10.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.